Study: Babies on Antacids Face Food Allergy Risks

baby regurgitating

Babies given antacids called proton pump inhibitors (PPIs) face a greater risk of developing food allergies and other problems, researchers say in a new study.

Drugs like Zantac or Prevacid may disrupt the development of beneficial organisms crucial to maintaining healthy immune systems.

Published last week in JAMA Pediatrics, this study is the largest of its kind, examining records of nearly 800,000 children.

Researchers found the risk of developing food allergies doubled for babies who received PPIs.

They also found a 50 percent jump in the risk for developing drug allergies.

The findings add to existing evidence that interfering with helpful “gut flora” in infancy can increase the risk for allergic diseases later in life.

“I did find it striking that we found positive associations between the use of antacid medications and virtually every class of allergy we evaluated,” lead author Dr. Edward Mitre told CBS News.

Are you suffering from complications after taking a PPI? Get a Free Case Review

Mitre is an associate professor in the Department of Microbiology and Immunology at the Uniformed Services University in Bethesda, Maryland.

He said the study’s findings counter the belief that PPIs are generally safe. This is especially true for infants whose digestive systems are still developing.

Results from the study further concluded that drugs like PPIs should only be used in infants when there is a clear clinical benefit.

PPIs are often given to infants for gastroesophageal reflux (GERD) symptoms. These symptoms include “spitting up” (regurgitation) and fussiness.

But trials have not found any clear clinical benefit of using these medications in infants.

Also, rarely is infant regurgitation part of a disease. Rather it is part of the normal developmental process.

Overusing PPIs in infancy may lead to reduced protein digestion. This causes a change in the processing of ingested antigens in the intestines.

Antigens are substances that can trigger an immune response, resulting in an allergic reaction.

This isn’t the first time the safety of PPIs in infancy has been called into question.

A 2017 study published in JAMA found a heightened risk of bone fractures in infants given PPIs or other similar mediations. The study found that acid-suppressive drugs taken in infancy may lead to a greater risk of children having bone fractures later in life.

  •  
  •  
  •  

Did you find Drugwatch helpful?

6 Cited Research Articles

  1. Mitre, E. et al. (2018, April 2). Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood. JAMA Pediatrics. Retrieved from https://jamanetwork.com/journals/jamapediatrics/fullarticle/2676167
  2. Mozes, A. (2018, April 3). Babies given antacids, antibiotics may have higher risk for allergies, asthma. Chicago Tribune. Retrieved from http://www.chicagotribune.com/lifestyles/health/sc-hlth-babies-antacids-antibiotics-risk-0411-story.html
  3. Medline Plus. (2017, August 26). Antigen. U.S. National Library of Medicine. NIH. Retrieved from https://medlineplus.gov/ency/article/002224.htm
  4. Johnson, C. (2018, April 2). Antacids, antibiotics for infants linked to later allergies. Retrieved from https://www.washingtonpost.com/national/health-science/antacids-antibiotics-for-infants-linked-to-later-allergies/2018/04/02/1b6d5624-3687-11e8-af3c-2123715f78df_story.html
  5. Rahhal, Natalie. (2018, April 2). Babies given antibiotics and antacids are up to 400% more likely to develop allergies and eczema, study finds. Retrieved from http://www.dailymail.co.uk/health/article-5570033/Babies-given-antibiotics-antacids-400-likely-develop-allergies
  6. Mozes, Alan. (2018, April 3). Certain meds may increase baby's risk of allergies. Retrieved from https://www.cbsnews.com/news/antibiotics-antacids-may-increase-babys-risk-of-allergies/
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(844) 440-8662

To contact Drugwatch Managing Editor Kevin Connolly, call (855) 839-9780.

Live Chat Icon livechat loading spinner